Literature DB >> 14962653

Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis.

Olivier Bonnefoy1, Gilbert Ferretti, Olivier Calaque, Max Coulomb, Hugues Begueret, Marie Beylot-Barry, François Laurent.   

Abstract

OBJECTIVE: A retrospective study was carried out in two institutions to determine serial changes in the pattern, distribution, and extent of interstitial lung disease (ILD) associated with polymyositis (PM)-dermatomyositis (DM) using HRCT. SUBJECTS AND METHODS: Twenty patients with PM-DM and clinical suspicion of ILD who underwent at least two serial HRCT examinations were retrospectively evaluated by two readers. Patients were classified according to the dominant CT pattern which was correlated with clinical evolution and underlying histology when available (n=6).
RESULTS: Patients were classified into four groups according to the dominant pattern: ground-glass attenuation and reticulation (group 1, n=9); honeycombing (group 2, n=4); airspace consolidation (group 3, n=4), and normal or almost normal lung (group 4, n=3). Under medical treatment, serial HRCT showed that the extent of areas of ground-glass opacities (group 1) decreased in five patients, stabilized in two, and increased in two. Pathologic findings demonstrated usual interstitial pneumonia (UIP) in two cases and unspecified interstitial pneumonia in one. In group 2, extent of honeycombing increased in three cases and stabilized in one. In group 3, dramatic resolution of airspace consolidation occurred in three cases. Clinical deterioration with extensive consolidation at CT and diffuse alveolar damage (DAD) at histology occurred in one patient of each of the three previous groups. Lesions stayed invisible or progressed slightly in the fourth group.
CONCLUSION: In ILD associated with PM-DM, clinical deterioration and DAD in the follow-up can be observed whatever the HRCT pattern. However, unfavorable evolution is constant when honeycombing is present at the initial CT.

Entities:  

Mesh:

Year:  2004        PMID: 14962653     DOI: 10.1016/S0720-048X(03)00094-9

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  12 in total

1.  Interstitial Lung Disease in Idiopathic Inflammatory Myopathy.

Authors:  Lesley Ann Saketkoo; Dana P Ascherman; Vincent Cottin; Lisa Christopher-Stine; Sonye K Danoff; Chester V Oddis
Journal:  Curr Rheumatol Rev       Date:  2010-05

Review 2.  Interstitial lung disease in polymyositis and dermatomyositis.

Authors:  Armin Schnabel; Bernhard Hellmich; Wolfgang Ludwig Gross
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

Review 3.  Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis.

Authors:  Patrick D W Kiely; Felix Chua
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

4.  Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.

Authors:  Shuang Ye; Xiao-xiang Chen; Xiao-ye Lu; Mei-fang Wu; Yun Deng; Wen-qun Huang; Qiang Guo; Cheng-de Yang; Yue-ying Gu; Chun-de Bao; Shun-le Chen
Journal:  Clin Rheumatol       Date:  2007-02-17       Impact factor: 2.980

5.  Differing distributions of CXCR3- and CCR4-positive cells among types of interstitial pneumonia associated with collagen vascular diseases.

Authors:  Shigeki Shimizu; Takeo Yoshinouchi; Takashi Niimi; Yuji Ohtsuki; Jiro Fujita; Hiroyoshi Maeda; Shigeki Sato; Ichiro Yamadori; Tadaaki Eimoto; Ryuzo Ueda
Journal:  Virchows Arch       Date:  2006-11-24       Impact factor: 4.064

6.  Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.

Authors:  Amandine Laporte; Kubéraka Mariampillai; Yves Allenbach; Nicoletta Pasi; Victoria Donciu; Dan Toledano; Benjamin Granger; Olivier Benveniste; Philippe A Grenier; Samia Boussouar
Journal:  Eur Radiol       Date:  2022-01-13       Impact factor: 5.315

Review 7.  The utility of comprehensive autoantibody testing to differentiate connective tissue disease associated and idiopathic interstitial lung disease subgroup cases.

Authors:  Caroline V Cotton; Lisa G Spencer; Robert P New; Robert G Cooper
Journal:  Rheumatology (Oxford)       Date:  2017-08-01       Impact factor: 7.580

8.  Evaluation of computer-based computer tomography stratification against outcome models in connective tissue disease-related interstitial lung disease: a patient outcome study.

Authors:  Joseph Jacob; Brian J Bartholmai; Srinivasan Rajagopalan; Anne Laure Brun; Ryoko Egashira; Ronald Karwoski; Maria Kokosi; Athol U Wells; David M Hansell
Journal:  BMC Med       Date:  2016-11-23       Impact factor: 8.775

9.  Serum levels of interleukins and S100A8/A9 correlate with clinical severity in patients with dermatomyositis-associated interstitial lung disease.

Authors:  Yueyan Lou; Yu Zheng; Bijun Fan; Liyan Zhang; Feng Zhu; Xiaodong Wang; Zhiwei Chen; Xiaoming Tan; Qing Wei
Journal:  BMC Pulm Med       Date:  2020-07-17       Impact factor: 3.317

10.  Severe juvenile dermatomyositis: two patients complicated with extra musculocutaneous involvement.

Authors:  Ayşe Tosun; Gül Serdaroğlu; Mehmet Tayyip Aslan; Muzaffer Polat; Taner Akalin; Hasan Tekgul; Sarenur Gökben
Journal:  Rheumatol Int       Date:  2006-05-24       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.